Assessing the cost of parathyroidectomy 2010 FOTHERINGHAM.pdf (174.12 kB)
Download fileAssessing the cost of parathyroidectomy as a treatment for uncontrolled secondary hyperparathyroidism in stage 5 chronic kidney disease
poster
posted on 2020-02-25, 10:52 authored by James Fotheringham, Alejandra DuenasAlejandra Duenas, Andrew RawdinAndrew Rawdin, Martin Wilkie, B. Harrison, Ronald AkehurstRonald AkehurstConventional therapy for chronic kidney disease mineral bone disorder includes control of serum phosphate with phosphate binders and the supplementation
of activated vitamin D. In many cases this proves inadequate, and in the UK parathyroidectomy (PTX) is recommended for patients who are otherwise surgical
fit as it is perceived as less costly than calcimemetics. However, no details of the true cost of PTX have been published.
AIMS: To describe the healthcare resource use and costs associated with patients receiving PTX as a treatment for uncontrolled secondary
hyperparathyroidism in a single UK National Health Service (NHS) centre (Sheffield Kidney Institute).
History
Ethics
- There is no personal data or any that requires ethical approval
Policy
- The data complies with the institution and funders' policies on access and sharing
Sharing and access restrictions
- The data can be shared openly
Data description
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files